Tech Company Financing Transactions

Neurona Therapeutics Funding Round

On 2/9/2024, Neurona Therapeutics raised $120 million in financing from Cormorant Asset Management, Viking Global Investors and Alexandria Venture Investments.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

170 Harbor Way
San Francisco, CA 94080
USA

Phone

Undisclosed

Website

www.neuronatherapeutics.com

Email Address

[email protected]

Overview

Neurona Therapeutics is a pre-clinical stage biotechnology company that was founded by four leading-edge neuroscientists and stem cell pioneers at The University of California, San Francisco. We are focused on the discovery and development of cell-based therapies to treat intractable neurological disease.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chairman

Timothy Kutzkey

        

Chief Executive Officer

Cory Nicholas

        

VP - Bus. Development

Michael Greenberg

        

VP - Bus. Development

Catherine Priest

        

VP - Finance

James Tanaka

        

VP - Human Resources

Celinda Moore

        

VP - Manufacturing

Gautam Banik

        

VP - Operations

Alessandro Bulfone

        

VP - Regulatory Affairs

Estela Alvarez

        

VP - Regulatory Affairs

Paurene Duramad

        

VP - Regulatory Affairs

Sergei Shevchuk

        

Browse more venture capital transactions:

Prev: 2/9/2024: Portchain venture capital transaction
Next: 2/9/2024: Myrspoven venture capital transaction

Share this article

Where The Data Comes From

We report on every notable VC transaction. All VC database entries reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary